Position in CRMD
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,558,067
-$820,093 QoQ
Shares Held
229,465
+12.2% QoQ
Ownership
0.292%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Steward Partners Investment Advisory, LLC holds $46,353,076 across 170 Biotechnology names. CRMD ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
338,246 | $11,006,524 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,863 | $7,976,544 | |
| 3 | ARGX |
Argenx SE
|
9,371 | $6,843,172 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,620 | $3,569,596 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
35,027 | $1,978,675 | |
| 6 | CRMD |
CorMedix Inc.
This page
|
229,465 | $1,558,067 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
146,453 | $1,176,017 | |
| 8 | NKTR |
Nektar Therapeutics
|
15,526 | $1,117,095 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,558,067 | 229,465 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,378,160 | 204,485 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,208,304 | 189,880 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,039,723 | 165,562 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $983,363 | 159,637 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,213,655 | 149,834 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,184,633 | 146,613 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $617,903 | 142,703 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $669,551 | 157,913 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $518,910 | 138,008 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $495,108 | 133,813 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $522,900 | 131,713 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $582,621 | 138,062 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $402,035 | 142,062 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $597,339 | 148,592 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $798,326 | 145,680 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $668,304 | 146,880 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $781,502 | 168,065 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,009,551 | 147,165 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,383,914 | 138,530 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $558,802 | 75,209 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $459,546 | 76,210 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $504,063 | 80,010 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $268,122 | 74,686 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||